Close
CDMO Safety Testing 2026
Novotech

Sinocompound expands range with new advanced high-quality Buchwald ligands and precatalysts

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Nestlรฉ and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlรฉ Health Science and IdB Holding have officially announced...

CordenPharma Seals AmbioPharm Deal to Expand Global Network

CordenPharma, a global contract development and manufacturing organization specializing...

Shilpa Biologicals Urges Stronger CDMO Selection Strategy

Ahead of BIO San Diego next month, Shilpa Biologicals...
- Advertisement -

Sinocompound Catalysts Co., Ltd has added to its established range of Buchwald ligands and precatalysts providing customers with even greater choice of ligands to meet their cross-coupling needs. Sinocompound is a specialist global provider of advanced homogeneous catalysts and ligands for pharmaceutical and fine chemical applications.

The latest additions to the Sinocompound Buchwald range include AdCyBrettPhos (CAS 2197989-24-3), AlPhos (CAS 1805783-60-1), EPhos Pd G4 (CAS 2132978-44-8), EPhos (CAS 2118959-55-8), AdBrettPhos (CAS 1160861-59-5), and AdBrettPhos Pd G3 (CAS 1445972-29-1).

Buchwald ligands are electron-rich dialkylbiaryl phosphines that are used to improve chemical reactivity in palladium catalysis. Even minor structural changes to Buchwald ligands can dramatically affect their catalytic activity in cross-coupling reactions with different substrates, which has led to the development of numerous ligands tailored for use in specific reactions. Buchwald ligands play an important role in the synthesis of pharmaceuticals, agrochemicals and organic electronic materials.

Sinocompound has been manufacturing high quality Buchwald ligands and precatalysts under license from MIT since 2012 and has continued to expand the product range by adding more advanced ligands to the family. While some Buchwald ligands are currently manufactured at a relatively small scale (grams), others are routinely manufactured at a larger scale (hundreds of kilograms).

With the opening of a new manufacturing plant in Tongling, Anhui Province, China, in the fourth quarter of 2021, Sinocompound is well placed to scale up production of Buchwald ligands to the meet the demands of customers.

Carin Seechurn, Technical Advisor, said, “At Sinocompound, weโ€™re always looking to build out our product ranges with the ligands our customers need for their specialist applications. Our new manufacturing facility combined with a flexible approach, advanced technology and in-house expertise, mean we can not only achieve short lead times but we can also rapidly scale up production as required to fulfil individual orders.”

About Sinocompound

Sinocompound Catalysts Co., Ltd. is a global provider of advanced homogeneous catalysts and ligands for a range of pharmaceutical and fine chemical applications. The companyโ€™s proven process is built around cutting-edge technology, flexibility, and speed-of-response ensuring delivery at the scale required. Established partnerships across industry and academia enable the development of novel chemistry; helping customers accelerate their route to market.
Established in 2008 and with headquarters in Zhangjiagang, China, Sinocompound focuses on listening to customers and delivering the high-quality catalyst technology they require โ€“ including homo- and heterogeneous metal catalysts, ligands, high-purity electronic and custom synthesis service.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Nestlรฉ and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlรฉ Health Science and IdB Holding have officially announced...

CordenPharma Seals AmbioPharm Deal to Expand Global Network

CordenPharma, a global contract development and manufacturing organization specializing...

Shilpa Biologicals Urges Stronger CDMO Selection Strategy

Ahead of BIO San Diego next month, Shilpa Biologicals...

Chemspec Europe 2026 Draws Global Industry Participation

Chemspec Europe returned to Cologne on 6โ€“7 May 2026,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป